Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
229-231 No difference in Hct or ESA responsiveness was found between groups
Metabolites with VIP 1 and fold change 2 or fold change 0.5 were considered differentially expressed metabolites (DEMs)
The SURMOUNT trials demonstrated average weight loss of 20 to 25 percent of body weight, numbers that exceeded anything previously seen with pharmaceutical interventions
doi: 10.1016/s0014-2999(99)00486-0
10.1210/endrev/bnac033 11 DarbalaeiS.ChangR
Evidence & References Billings LK, et al
US$ 28.52
US$ 27.99
US$ 26.71
US$ 23.52
US$ 25.16
US$ 21.93
US$ 24.29
US$ 24.37
